AI Meets Chemistry

Artificial intelligence can screen millions of molecular candidates in days, predict target binding, and flag likely toxicity early. Work that took years now starts faster.

AlphaFold by DeepMind made a major leap in predicting a protein's likely 3D structure from its amino acid sequence. That matters because drug design often depends on knowing the shape of a target protein. But it did not make experiments obsolete or solve every part of protein folding: dynamic regions, multiple conformations, complexes, and the physical folding pathway can still require other methods and validation.